As a new diagnostic method, genetic testing using molecular markers (such as BRAF, RAS, and RET) is recommended for the auxiliary diagnosis of patients with thyroid nodules when cytological results are uncertain (Alexander et al. 2012; Duick et al. 2012). This evidence concerns the gene BRAF and thyroid nodule.